Biopharmaceuticals, CDMO
Araris Biotech AG is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich pioneering a novel antibody-drug conjugate (ADC)-linker technology. Their linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering. Their innovative approach has the potential to set new benchmarks in terms of development, analysis and performance.
Philipp Spycher
Nice Insight/That’s Nice
89 Fifth AvenueFifth FloorNew YorkNY 10003-3020
New York – San Diego – ChicagoLondon – Frankfurt – Shanghai
Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.